CRNX

Crinetics Pharmaceuticals, Inc.

Next Earnings

Aug 07, 2026

Net Activity (1Y)

-$8.9M

Net Activity (90D)

-$366K

Insider Activity Graph

(24 shown · 88 raw)

Green/Red bubbles = daily net insider value (size = magnitude), Blue line = daily close price, E = earnings-related SEC filing

Insider trades for this company
Insider	Title	Type	Date ↓	Shares	Value
Coelho Rogerio Vivaldi	—	Sale	2026-07-02	3,000	$120K
Stephanie Okey	—	Sale	2026-06-17	6,900	$246K
Jeff E. Knight	Chief Dev. & Operating Officer	Sale	2026-04-08	85,163	$3.4M
Jeff E. Knight	Chief Operating Officer	Sale	2026-03-16	9,911	$370K
Stephen F. Betz	Chief Scientific Officer	Sale	2026-03-16	10,612	$397K
Richard Scott Struthers	President & CEO	Sale	2026-03-16	21,981	$822K
Coelho Rogerio Vivaldi	—	Sale	2026-03-12	5,000	$181K
Tobin Schilke	Chief Financial Officer	Sale	2026-03-03	6,713	$266K
Stephanie Okey	—	Sale	2026-03-03	3,000	$119K
Isabel Kalofonos	Chief Commercial Officer	Sale	2026-01-05	2,500	$138K
Dana Pizzuti	Chief Med and Dev Officer	Sale	2025-12-01	5,000	$225K
Dana Pizzuti	Chief Med and Dev Officer	Sale	2025-11-03	5,000	$213K
Dana Pizzuti	Chief Med and Dev Officer	Sale	2025-10-01	5,000	$209K
Richard Scott Struthers	President & CEO	Sale	2025-09-26	4,000	$180K
Matthew K Fust	—	Sale	2025-09-26	16,000	$716K
Dana Pizzuti	Chief Med and Dev Officer	Sale	2025-09-02	5,000	$161K
Dana Pizzuti	Chief Med and Dev Officer	Sale	2025-08-22	30,000	$913K
Dana Pizzuti	Chief Med and Dev Officer	Sale	2025-08-20	6,492	$189K